NCT04445467View on ClinicalTrials.gov

An Adaptive Clinical Trial of Antivirals for COVID-19 Infection

PHASE2UnknownINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions

COVID

Interventions

DRUG

Favipiravir

Favipiravir

Trial Locations (1)

3004

Alfred Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayside Health

OTHER_GOV